160 related articles for article (PubMed ID: 19762066)
1. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer.
Won KY; Kim GY; Kim YW; Song JY; Lim SJ
Hum Pathol; 2010 Jan; 41(1):107-12. PubMed ID: 19762066
[TBL] [Abstract][Full Text] [Related]
2. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
Choi J; Jung W; Koo JS
Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
[TBL] [Abstract][Full Text] [Related]
3. Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung.
Won KY; Kim GY; Lim SJ; Kim YW
Hum Pathol; 2012 Jan; 43(1):62-8. PubMed ID: 21777947
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of bcl-2 expression among women with breast cancer in Libya.
Ermiah E; Buhmeida A; Khaled BR; Abdalla F; Salem N; Pyrhönen S; Collan Y
Tumour Biol; 2013 Jun; 34(3):1569-78. PubMed ID: 23417836
[TBL] [Abstract][Full Text] [Related]
7. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
[TBL] [Abstract][Full Text] [Related]
8. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters.
Baspinar S; Bircan S; Yavuz G; Kapucuoglu N
Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017
[TBL] [Abstract][Full Text] [Related]
9. [The expressions and correlation of bcl-2 and Beclin-1 in pancreatic cancer].
Cao SS; Su AP; Du XJ; Li A; Hu WM; Zhang ZD; Tian BL; Lu HM; Ke NW; He ZP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):156-60. PubMed ID: 22650021
[TBL] [Abstract][Full Text] [Related]
10. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues.
Yao Q; Chen J; Lv Y; Wang T; Zhang J; Fan J; Wang L
Tumour Biol; 2011 Dec; 32(6):1163-71. PubMed ID: 21861179
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear insulin receptor substrate 1 in breast cancer.
Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
[TBL] [Abstract][Full Text] [Related]
12. Expression of beclin 1 in primary salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53 and prognosis.
Jiang LC; Huang SY; Zhang DS; Zhang SH; Li WG; Zheng PH; Chen ZW
Braz J Med Biol Res; 2014 Feb; 47(3):252-8. PubMed ID: 24554038
[TBL] [Abstract][Full Text] [Related]
13. Expression of BRCA1 protein in breast cancer and its prognostic significance.
Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy.
Yang Q; Sakurai T; Yoshimura G; Suzuma T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
Oncol Rep; 2003; 10(1):121-5. PubMed ID: 12469156
[TBL] [Abstract][Full Text] [Related]
15. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors.
Jaafar H; Abdullah S; Murtey MD; Idris FM
Asian Pac J Cancer Prev; 2012; 13(8):3857-62. PubMed ID: 23098483
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
[TBL] [Abstract][Full Text] [Related]
18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
19. Correlations of bcl-2 expression with clinicopathological features in breast cancer.
Lee HD; Koo JY; Jung WH
Yonsei Med J; 1997 Aug; 38(4):206-11. PubMed ID: 9339128
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic correlation of autophagy-related Beclin-1 expression in gallbladder cancer.
Park JY; Kim HS; Cho H; Kim NC; Chae KH; Park WS; Kim YW
Hepatogastroenterology; 2014 Sep; 61(134):1494-500. PubMed ID: 25436332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
